Devonian Health Group Announces Completion of Enrollment in Its Phase 2 Clinical Trial of Thykamine™ for the Treatment of Mild-to-Moderate Atopic Dermatitis in Adult Population
Last-patient-last-visit took place on June 3rd, 2020 Top-line results expected to be reported in November 2020 QUEBEC CITY–(BUSINESS WIRE)–Devonian Health…